kabutan

HISAMITSU PHARMA, 0.2％ Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.

Mon Apr 13, 2026 3:30 pm JST Earnings

4530 HISAMITSU PHARMACEUTICAL CO.,INC. 【J-GAAP】

Earnings Report

HISAMITSU PHARMACEUTICAL CO.,INC. <4530> [TSE Prime] announced its financial results after the market closed on April 13th (15:30). The consolidated ordinary profit for the fiscal year ended February 2026 decreased by 0.2% from the previous period to 23.9 billion yen. Furthermore, the company did not disclose the performance outlook for the fiscal year ending February 2027.

At the same time, the company has left the annual dividend for the current term undetermined.

In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit amounted to 7.32 billion yen, a 2.9% decrease compared to the same period last year. The operating profit margin decreased from 12.7% in the same period last year to 10.9%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2024 141,706 13,167 19,649 13,969 181.6 85 Apr 11, 2024 J-GAAP
Feb, 2025 156,006 18,895 24,010 21,758 295.6 90 Apr 10, 2025 J-GAAP
Feb, 2026 163,024 17,917 23,952 19,160 268.6 60 Apr 13, 2026 J-GAAP
YoY +4.5% -5.2% -0.2% -11.9% -9.1%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2026 Guidance ー ー ー ー － 60 Jan 6, 2026 J-GAAP
Feb, 2026 Results 163,024 17,917 23,952 19,160 268.6 60 Apr 13, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2025 74,943 8,128 10,089 7,022 97.0 60 Oct 9, 2025 J-GAAP
Mar - Aug, 2026 Guidance ー ー ー ー － － Apr 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2025 156,006 18,895 24,010 21,758 295.6 90 Apr 10, 2025 J-GAAP
Feb, 2026 163,024 17,917 23,952 19,160 268.6 60 Apr 13, 2026 J-GAAP
Feb, 2027 Guidance ー ー ー ー － － Apr 13, 2026 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2024 44,753 5,675 7,539 8,098 110.0 12.7 Apr 10, 2025 J-GAAP
Mar - May, 2025 34,665 3,364 3,780 2,564 35.1 9.7 Jul 10, 2025 J-GAAP
Jun - Aug, 2025 40,278 4,764 6,309 4,458 61.6 11.8 Oct 9, 2025 J-GAAP
Sep - Nov, 2025 39,571 4,480 6,541 4,868 67.9 11.3 Jan 6, 2026 J-GAAP
Dec - Feb, 2025 48,510 5,309 7,322 7,270 101.9 10.9 Apr 13, 2026 J-GAAP
YoY +8.4% -6.4% -2.9% -10.2% -7.4%

Related Articles